Empagliflozin Attenuates Arrhythmias in an iPSC-Based Model of Hypertrophic Cardiomyopathy.

Authors :: Arthur Ataam J
Belbachir N
Perea-Gil I
Termglinchan V
Vadgama N
Garg P
Ramchandani R
Gavidia AA
Roura S
Gálvez-Montón C
Wu JC
Bayés-Genis A
Karakikes I
Source :: Circulation. Genomic and precision medicine [Circ Genom Precis Med] 2024 Jun; Vol. 17 (3), pp. e004526. Date of Electronic Publication: 2024 May 16.
Publication Year :: 2024
Abstract: Competing Interests: Disclosures None.

Subjects :: Humans
Sodium-Glucose Transporter 2 Inhibitors therapeutic use
Sodium-Glucose Transporter 2 Inhibitors pharmacology
Cardiomyopathy, Hypertrophic drug therapy
Cardiomyopathy, Hypertrophic pathology
Cardiomyopathy, Hypertrophic genetics
Glucosides therapeutic use
Glucosides pharmacology
Benzhydryl Compounds therapeutic use
Benzhydryl Compounds pharmacology
Induced Pluripotent Stem Cells metabolism
Induced Pluripotent Stem Cells cytology
Arrhythmias, Cardiac drug therapy
Arrhythmias, Cardiac pathology

Full Text Access

Tools